Halozyme Therapeutics, Inc. (HALO) stock saw a modest uptick, ending the day at $62.3 which represents a slight increase of $1.76 or 2.91% from the prior close of $60.54. The stock opened at $61.02 ...
Investors are facing the busiest quarterly rebalancing in about four years on Friday in a shake-up that could affect roughly $250 billion worth of stocks, according to a team of equity analysts at ...
Results that may be inaccessible to you are currently showing.